Review



small animal dxa scanner osteosys insight  (OSTEOSYS CO LTD)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    OSTEOSYS CO LTD small animal dxa scanner osteosys insight
    GSK3β phosphorylation and content in femur samples obtained from male RR9 mice (A and B) Bone mineral content (BMC) and bone mineral density (BMD) of the individual bones obtained from a small <t>animal</t> <t>DXA</t> scanner. (C) Representative western blot images of phosphorylated (Ser9) and total GSK3β. (D and E) Western blot analysis of phosphorylated (Ser9) and total GSK3β content normalized to ponceau. (F) GSK3 activation status measured as the ratio of phosphorylated (Ser9) GSK3β relative to total GSK3β. (G) Representative DXA scan showing region-specific analysis of the femur, tibia, and lumbar spine in mice. (H) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured at baseline. (I) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (J) Western blot analysis of soleus muscle FNDC5 from GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (K) Proposed tissue crosstalk between muscle and bone with muscle-specific Gsk3 deletion leading to an increase in FNDC5 and tibia BMD. ∗p < 0.05, ∗∗∗p < 0.001 using a Student’s t test (n = 6–12 per group for (A–F); n = 3–5 per group for (H–J). For (A–F), GC and VIV controls were combined to increase statistical power. All values are presented as means ± SEM.
    Small Animal Dxa Scanner Osteosys Insight, supplied by OSTEOSYS CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insight+small+animal+dxa+scanner/small+animal+dxa+scanner+osteosys+insight/pmc10285634-230-1-5
    Average 90 stars, based on 1 article reviews
    small animal dxa scanner osteosys insight - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Toward countering muscle and bone loss with spaceflight: GSK3 as a potential target"

    Article Title: Toward countering muscle and bone loss with spaceflight: GSK3 as a potential target

    Journal: iScience

    doi: 10.1016/j.isci.2023.107047

    GSK3β phosphorylation and content in femur samples obtained from male RR9 mice (A and B) Bone mineral content (BMC) and bone mineral density (BMD) of the individual bones obtained from a small animal DXA scanner. (C) Representative western blot images of phosphorylated (Ser9) and total GSK3β. (D and E) Western blot analysis of phosphorylated (Ser9) and total GSK3β content normalized to ponceau. (F) GSK3 activation status measured as the ratio of phosphorylated (Ser9) GSK3β relative to total GSK3β. (G) Representative DXA scan showing region-specific analysis of the femur, tibia, and lumbar spine in mice. (H) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured at baseline. (I) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (J) Western blot analysis of soleus muscle FNDC5 from GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (K) Proposed tissue crosstalk between muscle and bone with muscle-specific Gsk3 deletion leading to an increase in FNDC5 and tibia BMD. ∗p < 0.05, ∗∗∗p < 0.001 using a Student’s t test (n = 6–12 per group for (A–F); n = 3–5 per group for (H–J). For (A–F), GC and VIV controls were combined to increase statistical power. All values are presented as means ± SEM.
    Figure Legend Snippet: GSK3β phosphorylation and content in femur samples obtained from male RR9 mice (A and B) Bone mineral content (BMC) and bone mineral density (BMD) of the individual bones obtained from a small animal DXA scanner. (C) Representative western blot images of phosphorylated (Ser9) and total GSK3β. (D and E) Western blot analysis of phosphorylated (Ser9) and total GSK3β content normalized to ponceau. (F) GSK3 activation status measured as the ratio of phosphorylated (Ser9) GSK3β relative to total GSK3β. (G) Representative DXA scan showing region-specific analysis of the femur, tibia, and lumbar spine in mice. (H) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured at baseline. (I) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (J) Western blot analysis of soleus muscle FNDC5 from GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (K) Proposed tissue crosstalk between muscle and bone with muscle-specific Gsk3 deletion leading to an increase in FNDC5 and tibia BMD. ∗p < 0.05, ∗∗∗p < 0.001 using a Student’s t test (n = 6–12 per group for (A–F); n = 3–5 per group for (H–J). For (A–F), GC and VIV controls were combined to increase statistical power. All values are presented as means ± SEM.

    Techniques Used: Phospho-proteomics, Western Blot, Activation Assay


    Figure Legend Snippet:

    Techniques Used: Software

    Related Articles

    Software:

    Article Title: Toward countering muscle and bone loss with spaceflight: GSK3 as a potential target
    Article Snippet: V.1.7.3.1 software , Bruker microCT , N/A. .. Osteosys software for INSIGHT small animal DXA scanner , Scintica , https://www.scintica.com/wp-content/uploads/2022/03/FAQ-iNSiGHT-DXA_v0122-1.pdf. .. Aurora Scientific 600A software , Aurora Scientif



    Similar Products

    small animal dxa scanner osteosys insight  (OSTEOSYS CO LTD)
    90
    OSTEOSYS CO LTD small animal dxa scanner osteosys insight
    GSK3β phosphorylation and content in femur samples obtained from male RR9 mice (A and B) Bone mineral content (BMC) and bone mineral density (BMD) of the individual bones obtained from a small <t>animal</t> <t>DXA</t> scanner. (C) Representative western blot images of phosphorylated (Ser9) and total GSK3β. (D and E) Western blot analysis of phosphorylated (Ser9) and total GSK3β content normalized to ponceau. (F) GSK3 activation status measured as the ratio of phosphorylated (Ser9) GSK3β relative to total GSK3β. (G) Representative DXA scan showing region-specific analysis of the femur, tibia, and lumbar spine in mice. (H) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured at baseline. (I) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (J) Western blot analysis of soleus muscle FNDC5 from GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (K) Proposed tissue crosstalk between muscle and bone with muscle-specific Gsk3 deletion leading to an increase in FNDC5 and tibia BMD. ∗p < 0.05, ∗∗∗p < 0.001 using a Student’s t test (n = 6–12 per group for (A–F); n = 3–5 per group for (H–J). For (A–F), GC and VIV controls were combined to increase statistical power. All values are presented as means ± SEM.
    Small Animal Dxa Scanner Osteosys Insight, supplied by OSTEOSYS CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insight+small+animal+dxa+scanner/small+animal+dxa+scanner+osteosys+insight/pmc10285634-230-1-5
    Average 90 stars, based on 1 article reviews
    small animal dxa scanner osteosys insight - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    insight small animal dxa scanner  (OSTEOSYS CO LTD)
    90
    OSTEOSYS CO LTD insight small animal dxa scanner

    Insight Small Animal Dxa Scanner, supplied by OSTEOSYS CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insight+small+animal+dxa+scanner/insight+whole+body+dxa+scanner/pmc10285634-41-2-0
    Average 90 stars, based on 1 article reviews
    insight small animal dxa scanner - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    GSK3β phosphorylation and content in femur samples obtained from male RR9 mice (A and B) Bone mineral content (BMC) and bone mineral density (BMD) of the individual bones obtained from a small animal DXA scanner. (C) Representative western blot images of phosphorylated (Ser9) and total GSK3β. (D and E) Western blot analysis of phosphorylated (Ser9) and total GSK3β content normalized to ponceau. (F) GSK3 activation status measured as the ratio of phosphorylated (Ser9) GSK3β relative to total GSK3β. (G) Representative DXA scan showing region-specific analysis of the femur, tibia, and lumbar spine in mice. (H) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured at baseline. (I) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (J) Western blot analysis of soleus muscle FNDC5 from GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (K) Proposed tissue crosstalk between muscle and bone with muscle-specific Gsk3 deletion leading to an increase in FNDC5 and tibia BMD. ∗p < 0.05, ∗∗∗p < 0.001 using a Student’s t test (n = 6–12 per group for (A–F); n = 3–5 per group for (H–J). For (A–F), GC and VIV controls were combined to increase statistical power. All values are presented as means ± SEM.

    Journal: iScience

    Article Title: Toward countering muscle and bone loss with spaceflight: GSK3 as a potential target

    doi: 10.1016/j.isci.2023.107047

    Figure Lengend Snippet: GSK3β phosphorylation and content in femur samples obtained from male RR9 mice (A and B) Bone mineral content (BMC) and bone mineral density (BMD) of the individual bones obtained from a small animal DXA scanner. (C) Representative western blot images of phosphorylated (Ser9) and total GSK3β. (D and E) Western blot analysis of phosphorylated (Ser9) and total GSK3β content normalized to ponceau. (F) GSK3 activation status measured as the ratio of phosphorylated (Ser9) GSK3β relative to total GSK3β. (G) Representative DXA scan showing region-specific analysis of the femur, tibia, and lumbar spine in mice. (H) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured at baseline. (I) Region-specific BMD analysis in mobile GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (J) Western blot analysis of soleus muscle FNDC5 from GSK3 mKD and GSK3 flox mice measured after 7 days of HLS. (K) Proposed tissue crosstalk between muscle and bone with muscle-specific Gsk3 deletion leading to an increase in FNDC5 and tibia BMD. ∗p < 0.05, ∗∗∗p < 0.001 using a Student’s t test (n = 6–12 per group for (A–F); n = 3–5 per group for (H–J). For (A–F), GC and VIV controls were combined to increase statistical power. All values are presented as means ± SEM.

    Article Snippet: A small animal DXA scanner (OsteoSys InSIGHT, Scintica) was used to scan the individual femur bones collected from the RR9 mission.

    Techniques: Phospho-proteomics, Western Blot, Activation Assay

    Journal: iScience

    Article Title: Toward countering muscle and bone loss with spaceflight: GSK3 as a potential target

    doi: 10.1016/j.isci.2023.107047

    Figure Lengend Snippet:

    Article Snippet: A small animal DXA scanner (OsteoSys InSIGHT, Scintica) was used to scan the individual femur bones collected from the RR9 mission.

    Techniques: Software

    Journal: iScience

    Article Title: Toward countering muscle and bone loss with spaceflight: GSK3 as a potential target

    doi: 10.1016/j.isci.2023.107047

    Figure Lengend Snippet:

    Article Snippet: Osteosys software for INSIGHT small animal DXA scanner , Scintica , https://www.scintica.com/wp-content/uploads/2022/03/FAQ-iNSiGHT-DXA_v0122-1.pdf.

    Techniques: Software